You have 9 free searches left this month | for more free features.

Condition

Advanced Pancreatic Cancer (1)

Melanoma (1)

Metastatic Cancer (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Immodulon Therapeutics Ltd (3)

Collaborator

Study Documents

Intervention Type

drug (3)

biological (2)

Funder Type

Industry (3)

Study Type

Interventional (3)

imm-101

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Melanoma Trial in London, Manchester (Nivolumab, Ipilimumab, IMM-101)

Completed

Melanoma

Nivolumab
+2 more

London, United Kingdom
+1 more

Apr 6, 2022

Advanced Pancreatic Cancer Trial in Worldwide (IMM-101, Gemcitabine)

Completed

Advanced Pancreatic Cancer

IMM-101
Gemcitabine

Nicosia, Strovolos, Cyprus
+20 more

Nov 3, 2021

Metastatic Cancer Trial in Lyon, Villejuif, London (IMM-101, Gemcitabine, Nabpaclitaxel)

Terminated

Metastatic Cancer

IMM-101
+11 more

Lyon, France
+3 more

Aug 8, 2018